Immunogenicity and Safety of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India.
Phase of Trial: Phase II
Latest Information Update: 30 Dec 2016
At a glance
- Drugs CYD TDV (Primary)
- Indications Dengue
- Focus Adverse reactions; Pharmacodynamics
- Sponsors sanofi pasteur
- 24 Aug 2016 Last checked against Clinical Trials Registry - India record.
- 24 Jul 2012 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India.
- 29 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.